Pathogenesis and treatment of multiple sclerosis-COMBINED ABSTRACT- This Program Project is to understand regulatory underlying inflammation in the central nervous system (CNS) as it relates to the human demyelinating disease, multiple sclerosis (MS). The approach seeks to abrogate CNS inflammation therapeutically and to up- regulate repair pathways pertinent to CNS remyelination While the etiology and pathogenesis of MS remain unknown, compelling evidence exists for immune-mediation in the demyelinated MS plaque and from a number of investigators on animal models, it has been shown that blocking of inflammation in the CNS frequently leads to remyelination. The Program combines the efforts of three independent investigators with different but complimentary skills who have worked together on MS for several years and who propose projects that target different hypotheses on factors regulating CNS inflammation. The first project (Raine) will examine autoimmune demyelination in a mouse lacking the chemokine receptor, CCR2, a molecule necessary in monocyte trafficking to sites of inflammation; the expression of a novel growth factor, glial growth factor 2, a known potentiator of remyelination, and its receptor, within the CNS of animals with demyelinating disease and in MS lesions; and progenitor oligodendrocytes in MS lesions of different ages The next project (Brosnan) targets mutations in chemokine receptors, their role and effects upon CNS inflammatory pathways and their presence in MS, and molecules related to the NF kappaB signaling cascade during inflammation and in MS lesions. The final project (Berman) will apply an in vitro model of the human blood-brain barrier (BBB) to the roles of chemokines and chemokine receptors in leukocyte migration into the CNS; the effect of the regulatory cytokine, IFNbeta, a cytokine used to treat MS, upon molecular expression (cytokine, chemokine and adhesion molecule), and alterations in the molecular profile of a number of pro- inflammatory mediators during leukocyte transmigration. Each of the projects will incorporate examination of MS material and their combination under one Program will be mutually reinforcing. Since a major driving concept in this proposal is that down-regulation of pro- inflammatory pathways is a factor sine qua non for the up-regulation of myelin repair genes and CNS remyelination in MS, this proposal may be of considerable therapeutic import for the MS patient.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1-SRB-W (04))
Program Officer
Kerza-Kwiatecki, a P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
Schools of Medicine
United States
Zip Code
Raine, Cedric S (2017) Multiple sclerosis: The resolving lesion revealed. J Neuroimmunol 304:2-6
Raine, Cedric S (2014) Autobiography series: a hitchhiker's road to neuropathology. J Neuropathol Exp Neurol 73:270-81
Brosnan, Celia F; Raine, Cedric S (2013) The astrocyte in multiple sclerosis revisited. Glia 61:453-65
D'Aversa, T G; Eugenin, E A; Lopez, L et al. (2013) Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis. Neuropathol Appl Neurobiol 39:270-83
Lutz, Sarah E; Raine, Cedric S; Brosnan, Celia F (2012) Loss of astrocyte connexins 43 and 30 does not significantly alter susceptibility or severity of acute experimental autoimmune encephalomyelitis in mice. J Neuroimmunol 245:8-14
Safavi, Farinaz; Feliberti, Jason P; Raine, Cedric S et al. (2011) Role of ?? T cells in antibody production and recovery from SFV demyelinating disease. J Neuroimmunol 235:18-26
Gaupp, Stefanie; Arezzo, Joseph; Dutta, Dipankar J et al. (2011) On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter? J Neuropathol Exp Neurol 70:1138-50
Lutz, Sarah E; Zhao, Yongmei; Gulinello, Maria et al. (2009) Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci 29:7743-52
Zhang, Yueting; Argaw, Azeb Tadesse; Gurfein, Blake T et al. (2009) Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci U S A 106:19162-7
Omari, Kakuri M; Lutz, Sarah E; Santambrogio, Laura et al. (2009) Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am J Pathol 174:164-76

Showing the most recent 10 out of 16 publications